Zolgensma, recently approved by the FDA, tops GoodRx's list of the 10 most expensive drugs in the U.S., with a $2.1 million price tag.
GoodRx's list includes both hospital-administered and patient-administered drugs.
The 10 most expensive drugs in the U.S.:
1. Zolgensma ($2,125,000)
2. Luxturna ($850,000)
3. Myalept ($850,000)
4. Folotyn ($745,785)
5. Soliris ($678,392)
6. Blincyto ($641,533)
7. Ravicti ($633,072)
8. Lumizyme ($630,630)
9. Actimmune ($575,540)
10. Takhzyro ($573,820)